NDC 68084-988-33 - Antacid Peppermint Flavour Regular Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-988
- Requested NDC
- 68084-988-33
- Package NDCs from labels
- 68084-988-33, 68084-988-32
- Manufacturer
- American Health Packaging
- Effective date
- 2024-11-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Antacid Peppermint Flavour Regular Strength - American Health Packaging | American Health Packaging | 2024-11-21 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-988-32 | AntacidPeppermint Flavour Regular Strength | 20 in 1 BOX, UNIT-DOSE | TABLET, CHEWABLE | 20 | 7 | |
| 68084-988-33 | AntacidPeppermint Flavour Regular Strength | 1 in 1 BLISTER PACK | TABLET, CHEWABLE | 1 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-988-32 | EA - Each | 68084-988 | daf14bf2-d3a2-4d41-be84-4c718d2e54a1 | 1 | 2016-01-13 |
| 68084-988-33 | EA - Each | 68084-988 | e1fdf052-4545-4012-9089-9e6b40dcc7ed | 1 | 2016-01-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tums Ultra | CALCIUM CARBONATE | Haleon US Holdings LLC | c544120f-15f0-48b5-88b2-d4820f180f50 | 2026-07-07 | Warnings | M001 H0G9379FGK |
| Regular Strength Assorted Flavors | ANTACID CALCIUM CARBONATE | AKRON PHARMA INC | 3f7fe022-aee9-b899-e063-6394a90afb4e | 2026-07-07 | Warnings | M001 308907 H0G9379FGK |
| Magnesium Oxide | MAGNESIUM OXIDE | Westminster Pharmaceuticals, LLC | 52eeac0e-94bb-48c3-81dc-578e96406c01 | 2026-07-06 | Warnings | M001 |
| Pepcid Complete | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | Select Consumer Group | 55cc3304-9094-3da8-e063-6394a90aa49b | 2026-07-04 | Warnings | H0G9379FGK |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 4c0dec79-1648-1cfd-e063-6394a90a88cc | 2026-07-03 | IY9XDZ35W2 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a82ea8-69bf-f061-e063-6394a90af3da | 2026-07-03 | IY9XDZ35W2 | |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 42ece7e1-1da1-7e5a-e063-6294a90ac803 | 2026-07-03 | IY9XDZ35W2 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a7d200-13cb-c0b0-e063-6294a90aafad | 2026-07-03 | IY9XDZ35W2 | |
| Kids Tummy Relief | CALCIUM CARBONATE | PNP Pharmaceuticals Inc. | 5103a317-5c4a-ec96-e063-6294a90aad7e | 2026-07-01 | Warnings | M001 H0G9379FGK |
| Childrens Antacid | CALCIUM CARBONATE | DOLGENCORP, LLC | 4d6ebc7e-ef39-47e8-91e9-f38484329fa9 | 2026-06-30 | Warnings | M001 H0G9379FGK |
| Ultra Strength Antacid | CALCIUM CARBONATE CHEWABLE TABLETS | CVS Pharmacy. Inc. | 24cec2bc-cf12-b513-e063-6394a90a9447 | 2026-06-30 | Warnings | M001 H0G9379FGK |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eab581-bc48-f9f0-e063-6394a90a4b93 | 2026-06-25 | IY9XDZ35W2 | |
| SET 4TE HOMO | ADEPS SUILLUS, BRYONIA (ALBA), CALCAREA PHOSPHORICA, CHOLINUM, DNA, DOPAMINE (HYDROCHLORIDE), FERRUM PHOSPHORICUM, FOLIC ACID, INSULINUM (HUMAN), LEPTIN, MAGNESIA MURIATICA, L-METHIONINE, METHYLCOBALAMIN, PROTEUS (VULGARIS), RHUS TOX, RIBOFLAVINUM, RUTA GRAVEOLENS, SACCHARUM OFFICINALE, THIOSINAMINUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | e7b8d75b-f2bc-4013-91e7-bf5bbec11a90 | 2026-06-25 | Warnings | C151H8M554 |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54fdf3cf-41df-af7d-e063-6294a90ab1e6 | 2026-06-24 | IY9XDZ35W2 | |
| Blood Collection System | CP2D/AS-3 TRIPLE WITH SAMPLING SYSTEM | GVS TM INC | 54e8cfd2-f91b-8381-e063-6394a90a3f77 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54e9a497-7a94-44c9-e063-6294a90a84da | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb0462-cd00-4467-e063-6394a90aa371 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb3c81-5cc8-03c4-e063-6294a90a2065 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54ebb700-3bcf-d0e3-e063-6394a90a57c8 | 2026-06-23 | IY9XDZ35W2 | |
| Vitramyn | FOLIC ACID | PureTek Corporation | c8af7616-5178-6df0-e053-2a95a90a334d | 2026-06-18 | Warnings, Adverse reactions | H0G9379FGK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.